Science Explorer Interactive view Map
Company · Waltham · United States

Kala Pharmaceuticals (United States)

kalarx.comROR OpenAlex
Research works
40
▼ 48% vs 2013–17
Citations
1.1k
28.2 per fractional work
Top-10% rate
14.8%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: Kala Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.66× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 6.73× its world share, 1 worksImmunology and Micro…Neuroscience: 3.13× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.40× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.11× its world share, 0 worksComputer ScienceEnvironmental Science: 0.68× its world share, 0 worksEnvironmental ScienceMathematics: 1.44× its world share, 0 worksMathematicsHealth Professions: 0.96× its world share, 0 worksHealth ProfessionsMedicine: 1.90× its world share, 4 worksMedicineDecision Sciences: 3.50× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.19× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.7×. Every wedge is a field page.

Which keywords describe research at Kala Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Drug Delivery, Cancer Therapy, Chitosan, Mucosal, Cancer, Dry Eye Disease and Ocular Surface.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 37 words, with their numbers
  1. Nanoparticles5▲ 9.8×8 topics
  2. Drug Delivery3▲ 17×2 topics
  3. Cancer Therapy3▲ 12×6 topics
  4. Cancer3▲ 5.2×9 topics
  5. Chitosan3▲ 132×1 topic
  6. Mucosal3▲ 261×1 topic
  7. Epidemiology3▲ 1.79×6 topics
  8. Inflammation2▲ 2.2×6 topics
  9. Dry Eye Disease2▲ 139×1 topic
  10. Ocular Surface2▲ 139×1 topic
  11. Glycosylation2▲ 20×2 topics
  12. Antibiotic Resistance2▲ 11×5 topics
  13. Gene Expression2▲ 7.0×4 topics
  14. Tumor Microenvironment2▲ 13×5 topics
  15. Oxidative Stress2▲ 2.2×8 topics
  16. Transcriptional Regulation2▲ 15×2 topics
  17. Breast Cancer1▲ 12×3 topics
  18. Epigenetic Regulation1▲ 17×2 topics
  19. Neurodegeneration1▲ 11×3 topics
  20. BET Bromodomains1▲ 162×1 topic
  21. HDAC Inhibitors1▲ 164×1 topic
  22. Histone Deacetylases1▲ 164×1 topic
  23. Immunotherapy1▲ 5.1×6 topics
  24. PROTACs1▲ 162×1 topic
  25. Metabolism1▲ 4.6×2 topics
  26. Therapeutics1▲ 21×2 topics
  27. Gene Therapy1▲ 11×2 topics
  28. Glycans1▲ 34×1 topic
  29. Immune System1▲ 8.6×1 topic
  30. Neuroinflammation1▲ 9.8×2 topics
  31. Tumor Targeting1▲ 21×2 topics
  32. CDK4/6 Inhibitors1▲ 165×1 topic
  33. Immunity1▲ 7.5×2 topics
  34. Monoclonal Antibodies1▲ 18×2 topics
  35. Palbociclib1▲ 165×1 topic
  36. Therapeutic Antibodies1▲ 20×2 topics
  37. Tumor Regression1▲ 29×2 topics

Which research topics does Kala Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Advanced Breast Cancer Therapies, Cancer Research and Treatments, Glycosylation and Glycoproteins Research and Immune cells in cancer.

Advanced Breast Cancer Therapies: 1 fractional worksCancer Research and Treatments: 1 fractional worksGlycosylation and Glycop…1Glycosylation and Glycoproteins Research: 1 fractional worksImmune cells in cancer1Immune cells in cancer: 1 fractional worksProtein Degradation and Inhibitors: 0 fractional worksAcute Myeloid Leukemia Research: 0 fractional worksAcne and Rosacea Treatme…0Acne and Rosacea Treatments and Effects: 0 fractional worksNeuroinflammation and Neurodegeneration Mechanisms: 0 fractional worksBacteriophages and microbial interactions: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional works
Pulmonary and Respiratory MedicineBiotechnologyMolecular BiologyImmunology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  4. 4 Immune cells in cancer Immunology 1 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 0 works
  6. 6 Acute Myeloid Leukemia Research Hematology 0 works
  7. 7 Acne and Rosacea Treatments and Effects Dermatology 0 works
  8. 8 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
  9. 9 Bacteriophages and microbial interactions Ecology 0 works
  10. 10 Cancer, Hypoxia, and Metabolism Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.8%not open64.2%

World: 28% of research is openly available.

with international co-authors28.7%domestic only71.3%

World: 19% is written across borders.

How has Kala Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 48% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.